Table 4 Prevalence of mucocutanous disorder among HIV infected children by WHO and CDC disease progression (n = 270)
Mucocutanous disorder | Mucocutanous disorder | Total | p value | |
|---|---|---|---|---|
Present n=196 | Absent n=74 | n=270 | ||
WHO pediatric stage | ||||
I | 5 (55.5) | 4 (44.5) | 9 (3.3) | |
II | 63 (61.2) | 40 (38.8) | 103 (38.2) | < 0.001 |
III | 80 (78) | 24 (22) | 104 (38.5) | |
IV | 48 (88.9) | 6 (11.1) | 54 (20) | |
Immunosuppression level by CDC | ||||
No evidence (category I) | 44 (48.3) | 47 (51.7) | 91 (33.7) | |
Moderate (category II) | 63 (70) | 27 (30) | 90 (33.3) | 0.000 |
Sever (category III) | 89 (100) | 0 (0) | 89 (33) | |
Mean cd4 | 456 (±285sd) | 646 (±270) | 0.026 |